Lixte Biotechnology Holdings Inc (LIXT)
2.89
+0.01
(+0.27%)
USD |
NASDAQ |
May 03, 16:00
2.89
0.00 (0.00%)
After-Hours: 20:00
Lixte Biotechnology Holdings Free Cash Flow (Quarterly): -0.9021M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.9021M |
| September 30, 2023 | -0.9444M |
| June 30, 2023 | -1.175M |
| March 31, 2023 | -1.271M |
| December 31, 2022 | -1.208M |
| September 30, 2022 | -1.174M |
| June 30, 2022 | -1.194M |
| March 31, 2022 | -1.035M |
| December 31, 2021 | -1.147M |
| September 30, 2021 | -0.9279M |
| June 30, 2021 | -1.042M |
| March 31, 2021 | -1.026M |
| December 31, 2020 | -0.739M |
| September 30, 2020 | -0.6237M |
| June 30, 2020 | -0.3546M |
| March 31, 2020 | -0.414M |
| December 31, 2019 | -0.3775M |
| September 30, 2019 | -0.5876M |
| June 30, 2019 | -0.3296M |
| March 31, 2019 | -0.3794M |
| December 31, 2018 | -0.5766M |
| September 30, 2018 | -0.1646M |
| June 30, 2018 | -0.272M |
| March 31, 2018 | -0.4977M |
| December 31, 2017 | -0.2843M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.4604M |
| June 30, 2017 | -0.3384M |
| March 31, 2017 | -0.329M |
| December 31, 2016 | -0.4698M |
| September 30, 2016 | -0.4801M |
| June 30, 2016 | -0.4016M |
| March 31, 2016 | -0.3259M |
| December 31, 2015 | -0.6123M |
| September 30, 2015 | -0.5089M |
| June 30, 2015 | -0.5213M |
| March 31, 2015 | -0.5386M |
| December 31, 2014 | -0.6444M |
| September 30, 2014 | -0.3378M |
| June 30, 2014 | -0.2937M |
| March 31, 2014 | -0.3596M |
| December 31, 2013 | -0.316M |
| September 30, 2013 | -0.2844M |
| June 30, 2013 | -0.2992M |
| March 31, 2013 | -0.2805M |
| December 31, 2012 | -0.2257M |
| September 30, 2012 | -0.2959M |
| June 30, 2012 | -0.4353M |
| March 31, 2012 | -0.249M |
| December 31, 2011 | -0.5656M |
| September 30, 2011 | -0.4042M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-1.271M
Minimum
Mar 2023
-0.3296M
Maximum
Jun 2019
-0.867M
Average
-0.9444M
Median
Sep 2023
Free Cash Flow (Quarterly) Benchmarks
| iBio Inc | -4.706M |
| PAVmed Inc | -12.06M |
| PDS Biotechnology Corp | -8.457M |
| Moleculin Biotech Inc | -5.488M |
| Syros Pharmaceuticals Inc | -18.60M |